3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Prostatic Neoplasms
14
Breast Neoplasms
12
Multiple Myeloma
8
Neoplasm Metastasis
5
Pain
4
Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Renal Insufficiency
1
Pleural Effusion, Malignant
1
Osteoporosis
1
Osteonecrosis
1
Osteolysis
1
Neoplastic Cells, Circulating
1
Lung Neoplasms
1
Lung Metastases
1
Carcinoma, Renal Cell
1
Bone Neoplasms
1
Bone Diseases, Metabolic
1
Interventions
Zoledronic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Osteonecrosis
×
Zoledronic Acid
×
Clear all
NCT02286830
2023-02-17
Magnolia
Odense University Hospital
Phase 4
Completed
158 enrolled